+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Inside the battle that's brewing as psychedelic companies fight for patent rights

Nov 9, 2021, 20:14 IST
Business Insider
Marianne Ayala/Insider

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...

A battle is brewing among psychedelics companies as they fight for investors, funding, and viable treatments. There's billions on the line.

Get an inside look>>

James Marshall, 5, pulls down his sleeve as his mother, Kristen, rear, looks on with her three-month-old daughter, Elizabeth, in a carriage after James received the Pfizer COVID-19 vaccine for children ages 5-11 at a state-run site in Cranston, R.I. AP Photo/David Goldman
One chart shows the most common side effects for kids after each dose of Pfizer's COVID-19 vaccine

See the full chart>>

Advertisement

White House Chief of Staff Ron Klain during an appearance on "Meet the Press" on November 7. NBC News/Meet the Press
White House chief of staff 'confident' Biden's COVID-19 vaccine mandate will be upheld after federal appeals court halted it

Check it out>>

More stories we're reading:

-Leah

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article